Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: oc631 post# 102102

Saturday, 08/21/2010 12:57:51 PM

Saturday, August 21, 2010 12:57:51 PM

Post# of 257580

Does anyone feel [VRUS’] guanine program was started after consultation with Roche or did VRUS act independently?

The latter. We know from the chronology that VRUS developed PSI-938 independently of the toxicity problems with ITMN-191. PSI-938 was formally announced by VRUS in Jul 2009 (#msg-39322313) and was obviously in the works for some time prior to that; ITMN’s revelation that ITMN-191 had serious toxicity problems occurred in Nov 2009 (#msg-43632598).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today